相关实验视频
Updated: Mar 18, 2026

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.8K
在接受呼吸道管理的儿科患者中进行神经肌肉阻塞:叙述性审查
Rachele Bonfiglio1, Hendrik von Eichstedt2, Alexander Fuchs2
1Unit for research in Anaesthesia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Current opinion in anaesthesiology
|March 16, 2026
概括
神经肌肉阻断剂 (NMBAs) 改善了儿科输管成功并减少了并发症. 定量监测和逆转药物,如sugammadex增强新生儿和婴儿的安全性,尽量减少残留块.
科学领域:
- 麻醉学 麻醉学
- 儿科重症监护 儿科重症监护
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿科患者的呼吸道管理,特别是新生儿和婴儿,具有显著的呼吸风险.
- 使用神经肌肉阻断剂 (NMBAs) 越来越多地支持优化通风和输管,当自发呼吸不需要时.
研究的目的:
- 审查NMBAs在儿科呼吸道管理中的不断变化的作用.
- 讨论新的药理选择和监测策略,以提高脆弱儿科群体的安全性.
主要方法:
- 随机试验,观察性研究和国际准则的审查.
- 关于新生儿和婴儿NMBA疗效和安全性的证据分析.
- 评估新的逆转剂和监测技术.
主要成果:
- NMBAs增强了第一次试验的气管管道输液成功,并减少了外科手术期间的呼吸系统不良事件.
- 罗库可以改善新生儿和婴儿的输管条件.
- 对两岁以下儿童的苏加马德克斯的批准扩大了安全的逆转选择.
- 定量神经肌肉监测优于检测残留神经肌肉阻塞的临床方法.
结论:
- 在不需要自发通风的情况下,NMBA对于儿科呼吸道管理至关重要.
- 常规使用定量监测和适当的药理逆转对于最大限度地减少残留阻塞和提高患者安全至关重要.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.1K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
3.4K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.4K
Neuromuscular Junction And Blockade
5.7K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.7K
Depolarizing Blockers: Mechanism of Action
3.3K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.3K
Depolarizing Blockers: Pharmocokinetics
695
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
695

